PMED — Peptonic Medical AB Balance Sheet
0.000.00%
- SEK24.28m
- SEK38.95m
- SEK26.89m
- 14
- 42
- 15
- 10
Annual balance sheet for Peptonic Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | — | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 39.4 | 10.2 | 3.57 | 15.1 | 3.74 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.51 | 5.69 | — | 6.37 | 2.74 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 55.6 | 27.1 | 31.4 | 40.4 | 12.6 |
| Net Property, Plant And Equipment | 1.51 | 4.2 | 4.3 | 3.78 | 0.402 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 111 | 83.5 | 85.8 | 107 | 70.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16.8 | 31.5 | 35.1 | 31.4 | 22 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 16.8 | 31.5 | 38.7 | 31.4 | 22 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 94.5 | 52 | 47.1 | 75.3 | 48.6 |
| Total Liabilities & Shareholders' Equity | 111 | 83.5 | 85.8 | 107 | 70.6 |
| Total Common Shares Outstanding |